362 related articles for article (PubMed ID: 9337531)
21. [Expression of adhesion molecules LFA-1 (CD11a and ICAM-1 (CD54) on lymphocytes and chemokines IL-8 and MCP-1 concentrations in bronchoalveolar lavage of patients with asthma or chronic obstructive pulmonary disease].
Jahnz-Rózyk K; Chciałowski A; Pirozyńska E; Rogalewska A
Pol Merkur Lekarski; 2000 Oct; 9(52):649-52. PubMed ID: 11144049
[TBL] [Abstract][Full Text] [Related]
22. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
[TBL] [Abstract][Full Text] [Related]
23. The clinical significance of interleukin 18 assessment in sarcoidosis patients.
Kieszko R; Krawczyk P; Jankowska O; Chocholska S; Król A; Milanowski J
Respir Med; 2007 Apr; 101(4):722-8. PubMed ID: 17015003
[TBL] [Abstract][Full Text] [Related]
24. Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Striz I
Respir Med; 2009 May; 103(5):773-9. PubMed ID: 19117745
[TBL] [Abstract][Full Text] [Related]
25. [Detection of TNF-alpha and NCF in the serum and BALF of patients with sarcoidosis and evaluate their clinical significance].
Li Z; Chen W; Hou X; Yu R
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jan; 22(1):37-9. PubMed ID: 11812354
[TBL] [Abstract][Full Text] [Related]
26. [Inhibitory effects of alpha 1 protease inhibitor on the production of IL-1 and TNF alpha by alveolar macrophages in patients with lung cancer].
Ameshima S; Ishizaki T; Takahashi H; Kishi Y; Sasaki F; Nakai T; Miyabo S
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):873-80. PubMed ID: 1630052
[TBL] [Abstract][Full Text] [Related]
27. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS
Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
29. [Immunological status of alveolar macrophages in patients with lung cancer and benign pulmonary diseases].
Liu C
Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):408-11, 446. PubMed ID: 1330230
[TBL] [Abstract][Full Text] [Related]
30. Bronchoalveolar lavage fluid alteration in antioxidant and inflammatory status in lung cancer patients.
Kontakiotis T; Katsoulis K; Hagizisi O; Kougioulis M; Gerou S; Papakosta D
Eur J Intern Med; 2011 Oct; 22(5):522-6. PubMed ID: 21925065
[TBL] [Abstract][Full Text] [Related]
31. Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy - Association of interleukin-8 and VEGF with survival.
Crohns M; Saarelainen S; Laine S; Poussa T; Alho H; Kellokumpu-Lehtinen P
Cytokine; 2010 Apr; 50(1):30-6. PubMed ID: 20044268
[TBL] [Abstract][Full Text] [Related]
32. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
33. [Levels of TNF-α, IL-6 and IL-10 in bronchoalveolar lavage fluid in children with Mycoplasma pneumoniae pneumonia].
Pang HX; Qiao HM; Cheng HJ; Zhang YF; Liu XJ; Li JZ
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Oct; 13(10):808-10. PubMed ID: 22000436
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
35. [Platelet activating factor and tumor necrosis factor-alpha in bronchoalveolar lavage fluid of patients with ARDS].
Matsumoto K; Taki F; Kondo Y; Taniguchi H; Takagi K; Matsuzaki M; Kayahara H
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Mar; 31(3):330-5. PubMed ID: 8315901
[TBL] [Abstract][Full Text] [Related]
36. Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues.
Saji H; Nakamura H; Awut I; Kawasaki N; Hagiwara M; Ogata A; Hosaka M; Saijo T; Kato Y; Kato H
Ann Thorac Cardiovasc Surg; 2003 Oct; 9(5):295-300. PubMed ID: 14672525
[TBL] [Abstract][Full Text] [Related]
37. Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.
Wu CL; Lee YL; Chang KM; Chang GC; King SL; Chiang CD; Niederman MS
Crit Care Med; 2003 Mar; 31(3):812-7. PubMed ID: 12626989
[TBL] [Abstract][Full Text] [Related]
38. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
[TBL] [Abstract][Full Text] [Related]
39. Serum and BAL cytokine and antioxidant enzyme levels at different stages of pneumoconiosis in coal workers.
Ulker O; Yucesoy B; Demir O; Tekin I; Karakaya A
Hum Exp Toxicol; 2008 Dec; 27(12):871-7. PubMed ID: 19273541
[TBL] [Abstract][Full Text] [Related]
40. [Detection and significance of interleukin-8,6, tumor necrosis factor-alpha in sputa from patients with chronic obstructive pulmonary disease].
Wang S; Xu F; Chen Y
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Aug; 23(8):465-7. PubMed ID: 11778258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
